Blue Horizon Enterprise Ltd 4
4 · Akero Therapeutics, Inc. · Filed Dec 5, 2022
Insider Transaction Report
Form 4
Skorpios Trust
10% Owner
Transactions
- Sale
Common Stock
2022-12-01$43.50/sh−1,636,000$71,166,000→ 3,271,829 total(indirect: See Footnote)
Footnotes (1)
- [F1]Blue Horizon Enterprise Ltd. ("Blue Horizon") is the direct owner of 2,346,298 shares of the issuer's common stock and Ezbon International Limited ("Ezbon") is the direct owner of 925,531 shares of the issuer's common stock. Skorpios Trust ("Skorpios") is the sole owner of each of Blue Horizon and Ezbon. Montrago Trustees Limited ("Montrago Trustees") is the corporate trustee of Skorpios Trust. Each of Blue Horizon and Ezbon disclaim beneficial ownership of the shares of the issuer's common stock held by the other, and each of Skorpios Trust and Montrago Trustees disclaim beneficial ownership of the issuer's securities except to the extent of their pecuniary interest therein.